In Model, In Vitro and In Vivo Killing Efficacy of Antitumor Peptide RDP22 on MUG-Mel2, a Patient Derived Cell Line of an Aggressive Melanoma Metastasis

M Wussmann; FK Groeber-Becker; Sabrina Riedl; D Alihodzic; D Padaric; L Gerlitz; Alexander Stallinger; Bernadette Liegl-Atzwanger; D Zweytick; Beate Rinner

doi:10.3390/biomedicines10112961

In Model, In Vitro and In Vivo Killing Efficacy of Antitumor Peptide RDP22 on MUG-Mel2, a Patient Derived Cell Line of an Aggressive Melanoma Metastasis

M Wussmann
, FK Groeber-Becker
, Sabrina Riedl
, D Alihodzic
, D Padaric
, L Gerlitz
, Alexander Stallinger
, Bernadette Liegl-Atzwanger
, D Zweytick
, Beate Rinner^* (Last author)

^*Corresponding author for this work

Research output: Contribution to journal › Research article

1 Citation (Web of Science)

Original language	English
Journal	Biomedicines
DOIs	https://doi.org/10.3390/biomedicines10112961
Publication status	Published - 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Branches of science

106 Biology
301 Medical-Theoretical Sciences, Pharmacy
305 Other Human Medicine, Health Sciences

DOI

10.3390/biomedicines10112961

Links

Cite this

Wussmann, M., Groeber-Becker, FK., Riedl, S., Alihodzic, D., Padaric, D., Gerlitz, L., Stallinger, A., Liegl-Atzwanger, B., Zweytick, D., & Rinner, B. (2022). In Model, In Vitro and In Vivo Killing Efficacy of Antitumor Peptide RDP22 on MUG-Mel2, a Patient Derived Cell Line of an Aggressive Melanoma Metastasis. Biomedicines. https://doi.org/10.3390/biomedicines10112961

@article{cc755958d8e7465fa195bec26ea2c02b,

title = "In Model, In Vitro and In Vivo Killing Efficacy of Antitumor Peptide RDP22 on MUG-Mel2, a Patient Derived Cell Line of an Aggressive Melanoma Metastasis",

author = "M Wussmann and FK Groeber-Becker and Sabrina Riedl and D Alihodzic and D Padaric and L Gerlitz and Alexander Stallinger and Bernadette Liegl-Atzwanger and D Zweytick and Beate Rinner",

year = "2022",

doi = "10.3390/biomedicines10112961",

language = "English",

journal = "Biomedicines",

issn = "2227-9059",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

}

TY - JOUR

T1 - In Model, In Vitro and In Vivo Killing Efficacy of Antitumor Peptide RDP22 on MUG-Mel2, a Patient Derived Cell Line of an Aggressive Melanoma Metastasis

AU - Wussmann, M

AU - Groeber-Becker, FK

AU - Riedl, Sabrina

AU - Alihodzic, D

AU - Padaric, D

AU - Gerlitz, L

AU - Stallinger, Alexander

AU - Liegl-Atzwanger, Bernadette

AU - Zweytick, D

A2 - Rinner, Beate

PY - 2022

Y1 - 2022

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000894804200001

UR - https://pubmed.ncbi.nlm.nih.gov/36428530

UR - https://pmc.ncbi.nlm.nih.gov/articles/PMC9687695

U2 - 10.3390/biomedicines10112961

DO - 10.3390/biomedicines10112961

M3 - Research article

C2 - 36428530

SN - 2227-9059

JO - Biomedicines

JF - Biomedicines

ER -